Berkshire Hathaway’s Sanofi SNY Stock Holding History

Berkshire Hathaway’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-3,701,012	Closed	-$148M	–	47
2018 Q2	$148M	Hold	3,701,012	–	–	0.08%	36
2018 Q1	$148M	Sell	3,701,012 -177,512	-5%	-$7.39M	0.08%	37
2017 Q4	$167M	Sell	3,878,524 -27,351	-0.7%	-$1.26M	0.09%	38
2017 Q3	$194M	Hold	3,905,875	–	–	0.11%	37
2017 Q2	$187M	Hold	3,905,875	–	–	0.12%	36
2017 Q1	$177M	Hold	3,905,875	–	–	0.11%	36
2016 Q4	$158M	Hold	3,905,875	–	–	0.11%	37
2016 Q3	$149M	Hold	3,905,875	–	–	0.12%	38
2016 Q2	$163M	Hold	3,905,875	–	–	0.13%	36
2016 Q1	$157M	Hold	3,905,875	–	–	0.12%	36
2015 Q4	$167M	Hold	3,905,875	–	–	0.13%	38
2015 Q3	$185M	Hold	3,905,875	–	–	0.15%	37
2015 Q2	$193M	Hold	3,905,875	–	–	0.18%	37
2015 Q1	$193M	Hold	3,905,875	–	–	0.18%	36
2014 Q4	$178M	Hold	3,905,875	–	–	0.16%	37
2014 Q3	$220M	Hold	3,905,875	–	–	0.2%	36
2014 Q2	$208M	Hold	3,905,875	–	–	0.19%	36
2014 Q1	$204M	Hold	3,905,875	–	–	0.19%	37
2013 Q4	$209M	Hold	3,905,875	–	–	0.2%	35
2013 Q3	$198M	Sell	3,905,875 -157,800	-4%	-$8.03M	0.21%	32
2013 Q2	$209M	Buy	+4,063,675	New	+$217M	0.23%	32

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Berkshire Hathaway's SNY Position: Q3 2018 in Review

Berkshire Hathaway sold out of Sanofi (SNY) in Q3 2018, closing a stake of 3,701,012 shares — an estimated $148M sold.

Berkshire Hathaway first reported a position in SNY in Q2 2013 and held it in 21 quarters. The position peaked at $220M in Q3 2014. 480 funds tracked by Wall St. Rank hold SNY as of Q3 2018.

Berkshire Hathaway reported no remaining Sanofi position as of Q3 2018 after selling out during the quarter.
Berkshire Hathaway sold 3,701,012 Sanofi shares in Q3 2018, an estimated $148M.
Berkshire Hathaway first reported a position in Sanofi in Q2 2013 and held it in 21 quarters.
Berkshire Hathaway's Sanofi position peaked at $220M in Q3 2014.
480 funds tracked by Wall St. Rank held Sanofi as of Q3 2018.

Based on Berkshire Hathaway's 13F filing for Q3 2018, filed 14 Nov 2018.